Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Effect of Inspiratory Breathing Muscle Exercise Using Respirometer on Changes in Lung Function and Dyspnea Severity in Tuberculosis Pleurisy Patients Irmaini Irmaini; Herry Priyanto; Dewi Behtri Yanifitri
Jurnal Respirologi Indonesia Vol 42, No 1 (2022)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v42i1.275

Abstract

Background: Respirometer has been commonly used to improve lung function, prevent atelectasis and respiratory complications after surgery. The effectiveness of respirometer to improve lung re-expansion in pleural effusion has not been well studied. So far there is no such study implemented to examine this association in pleural effusion particularly tuberculosis pleurisy in Aceh. Method: This was an experimental pretest-posttest controlled trial in patients with tuberculosis pleurisy hospitalized in dr. Zainoel Abidin Hospital between July and December 2019. Systematic random sampling was used to gather 40 samples, which then divided into intervention and control group consisted of 20 people in each group. All participants performed spirometry and were assessed for dyspnea severity using Borg scale after thoracocentesis and repeated 6 days later. Only intervention group received exercise using respirometer. Data were examined statistically using paired T-test and Mann Whitney Test. Results: The majority of participants were male (68%) with mean age of 42 years old. Around one-third of samples were smokers with mean Brinkman Index of 273 (moderate). The nutritional status was mostly good with mean BMI of 21 (normal). There were significant improvements of FEV1 and FVC values before and after 6 days in both groups. However, if the improvements were compared between intervention and control groups, only FVC improved significantly in intervention group (P= 0.019) whereas FEV1 improved in both groups without significant difference (P= 0.456). Similar result was seen in dyspnea severity where both groups experienced improvement after 6 days with or without intervention. Conclusion: Inspiratory muscle exercise using respirometer could improve lung function, particularly FVC value, significantly and could be an option for additional therapy to help lung re-expansion in tuberculosis pleurisy.
The Impact of Chest Therapy on Symptoms Relief and Pulmonary Function in Chronic Obstructive Pulmonary Disease Exacerbations Nurrahmah Yusuf; Yuris Hikman Karunia; Irmaini Irmaini; Yunita Arliny; Budi Yanti
Indonesian Journal of Global Health Research Vol 7 No 1 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i1.4998

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a global health concern defined by persistent respiratory symptoms and irreversible airflow blockage. Excess mucus production and decreased ciliary function in mucus elimination are two of the most common issues among COPD patients. Chest therapy is a physiotherapy practice that helps to remove mucus in a variety of acute and chronic respiratory illnesses. Objective: The study aims to explore how chest treatment affects symptoms and lung function in patients with COPD exacerbations. Methods: This study employed a one-group pretest-posttest design, selecting a sample of 30 COPD exacerbation patients from dr. Zainoel Abidin Hospital through convenience sampling technique. Chest therapy was administered consecutively over six days. Pulmonary function was assessed with a peak flow meter, while symptom improvement was assessed through the BORG questionnaire, Modified Medical Research Council (mMRC) scale, and COPD Assessment Test (CAT). Data analysis was performed using the paired T-test and Wilcoxon test. Results: Chest therapy increased average peak expiratory flow (PEF) by 6.40 L/min, from 29.20 ± 6.26 L/min to 35.60 ± 7.65 L/min. BORG scale scores were likewise reduced, with the majority shifting from scale 4 (56.7%) to scale 2 (40%), as were mMRC scores, which decreased from a dominant scale 3 (40%) to scale 2 (33.3%). Furthermore, CAT scores shifted from the high category (76.7%) to the moderate category (53.3%). Bivariate tests revealed that chest therapy had a significant effect on rising PEF values (P<0.001), decreasing BORG scale scores (P<0.001), and decreasing CAT scores (P = 0.001), but no significant effect was seen on the mMRC scale (P = 0.564). Conclusions: Chest therapy positively impacts lung function, as shown by increased peak expiratory flow (PEF) values and improved clinical symptoms of COPD exacerbation, as measured by BORG and CAT scale scores.